More hope for cancer-afflicted patients on anvil
The NAB technology is being tested in some other cancers like lung cancer and pancreatic cancer. In other cases, where credible breakthrough has lacked, experts are using a combination of anti-cancer drugs to increase their efficacy. Novartis’ Zometa and Glaxos’ Tykerb is being tried with other drugs that has showed almost 36% more survival in chronic breast cancer patients.
This entry was posted on Monday, June 23rd, 2008 at 12:37 pm and is filed under Research. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.